In the same line, prolactin also enhances Insulin growth factor 1 (IGF1)-induced phosphorylation of IGF1-receptor increasing its AKT and ERK1/2 downstream signaling associated with proliferation, survival and invasion of breast cancer cells. Here, PRL is linked to breast carcinoma.